194 related articles for article (PubMed ID: 24708203)
1. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.
Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B
Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203
[TBL] [Abstract][Full Text] [Related]
2. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of peppermint oil and (-)-menthol with respect to 5-HT3 receptor subtypes: binding studies, cation uptake by receptor channels and contraction of isolated rat ileum.
Heimes K; Hauk F; Verspohl EJ
Phytother Res; 2011 May; 25(5):702-8. PubMed ID: 21077259
[TBL] [Abstract][Full Text] [Related]
4. Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons.
Walstab J; Krüger D; Stark T; Hofmann T; Demir IE; Ceyhan GO; Feistel B; Schemann M; Niesler B
Neurogastroenterol Motil; 2013 May; 25(5):439-47, e302. PubMed ID: 23490018
[TBL] [Abstract][Full Text] [Related]
5. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors.
Walstab J; Hammer C; Bönisch H; Rappold G; Niesler B
Pharmacogenet Genomics; 2008 Sep; 18(9):793-802. PubMed ID: 18698232
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
8. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
9. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
[TBL] [Abstract][Full Text] [Related]
10. The Human Serotonin Type 3 Receptor Gene (HTR3A-E) Allelic Variant Database.
Celli J; Rappold G; Niesler B
Hum Mutat; 2017 Feb; 38(2):137-147. PubMed ID: 27763704
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.
Baptista-Hon DT; Deeb TZ; Othman NA; Sharp D; Hales TG
Br J Pharmacol; 2012 Feb; 165(3):693-704. PubMed ID: 21740409
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
Rojas C; Raje M; Tsukamoto T; Slusher BS
Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
[TBL] [Abstract][Full Text] [Related]
13. Visualising functional 5-HT
Abad IPL; Fam RL; Nguyen DT; Nowell CJ; Trinh PNH; Manallack DT; Freihat LA; Chakrabarti J; Jamil A; Exintaris B; Yaakob NS; Irving HR
Biomed Pharmacother; 2020 Dec; 132():110860. PubMed ID: 33059258
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
15. Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.
Machu TK
Pharmacol Ther; 2011 Jun; 130(3):338-47. PubMed ID: 21356241
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cholinergic nicotinic receptors in the menthol-induced gastric relaxation.
Amato A; Serio R; Mulè F
Eur J Pharmacol; 2014 Dec; 745():129-34. PubMed ID: 25446932
[TBL] [Abstract][Full Text] [Related]
17. Natural Negative Allosteric Modulators of 5-HT₃ Receptors.
Al Kury LT; Mahgoub M; Howarth FC; Oz M
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513973
[TBL] [Abstract][Full Text] [Related]
18. Recent advances with 5-HT
Juza R; Vlcek P; Mezeiova E; Musilek K; Soukup O; Korabecny J
Med Res Rev; 2020 Sep; 40(5):1593-1678. PubMed ID: 32115745
[TBL] [Abstract][Full Text] [Related]
19. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
Lochner M; Thompson AJ
Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
